BHARAT BIOTECH
Brazil Regulator Denies Certificate To Bharat Biotech, Flags Safety Issues In Covaxin Production – Three Concerns Highlighted
Covaxin, Bharat Biotech's COVID-19 Vaccine's Phase 2 Data In Lancet Magazine, It Says ‘It Is Safe, Induces Immune Response With No Severe Effects’
Bharat Biotech's Intranasal COVID-19 Vaccine Candidate in Early Clinical Stage of Development in India, Says MoS Ashwini Choubey
COVID-19 Vaccine Covaxin Phase 2 Data Shows Vaccine Safe, Induces Immune Response: Lancet Study
Covaxin Vaccine 'Safe, Immunogenic With No Serious Side Effects', Phase 3 Trial Results Needed to Test Effectiveness, Says Lancet
India Not Utilising COVID-19 Vaccine to Full Capacity, it is Either Donated or Sold Off to Foreign Countries, Says Delhi High Court
COVID-19 Vaccine Covaxin Shows 81% Efficacy in Phase 3 Clinical Trials, Says Bharat Biotech
Covaxin COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81% in Phase 3 Trials, Claims Bharat Biotech
Sharad Pawar, Amit Shah, Nitish Kumar, Yashwant Sinha Among Senior Politicians Who Got First Shot Of COVID-19 Vaccine
COVID-19 Vaccine Makers Serum Institute of India And Bharat Biotech Targetted by Chinese Hackers, Claims Report
PM Narendra Modi Taking COVID-19 Vaccine To Build Confidence in Vaccination Drive: Bharat Biotech
PM Narendra Modi Takes First Dose of COVID-19 Vaccine at AIIMS in Delhi, Sister P Niveda From Puducherry Administers Covaxin to the Prime Minister (Watch Video)
PM Narendra Modi Takes First Dose of COVID-19 Vaccine at AIIMS in Delhi, Appeals Eligible Citizens to Get Inoculated
Google Trends